© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Jason A. Efstathiou, MD, DPhil
Articles
Proton Radiotherapy for Prostate Cancer: How Did We Get Here, and Where Do We Go From Here?
December 15, 2013
Despite the promise of proton therapy, comparative evidence has yet to definitively demonstrate its clinical benefit over other forms of contemporary radiation for prostate cancer.
T1 High-Grade Bladder Cancer Recurring After BCGTherapy: A Curative Alternative to Radical Cystectomy Exists
September 15, 2013
Decades of experience now exist to support the use of chemoradiotherapy in the treatment of muscle-invasive bladder cancer. Chemoradiotherapy for T1 tumors that recur following bacillus Calmette-Guérin therapy is promising and provides an important curative alternative for those unable or unwilling to undergo radical cystectomy.
Management of Lymph Node–Positive Prostate Cancer: The Role of Surgery and Radiation Therapy
July 15, 2013
Current evidence for the management of lymph node–positive prostate cancer suggests both a disease-control and survival benefit to systemic ADT plus surgery and radiation.